keyword
https://read.qxmd.com/read/38621698/on-x-aortic-valve-replacement-patients-treated-with-low-dose-warfarin-and-low-dose-aspirin
#1
JOURNAL ARTICLE
Aung Y Oo, Mahmoud Loubani, Marc W Gerdisch, Joseph Zacharias, Geoffrey M Tsang, Michael J Perchinsky, Robert Carl Hagberg, Mark Joseph, Mohanakrishnan Sathyamoorthy
OBJECTIVES: To assess if warfarin targeted to INR 1.8 (range 1.5-2.0) is safe for all patients with an On-X aortic mechanical valve. METHODS: This prospective, observational registry follows patients receiving warfarin targeted at an INR of 1.8 (range 1.5-2.0) plus daily aspirin (75-100 mg) after On-X aortic valve replacement. The primary end-point is a composite of thromboembolism, valve thrombosis, and major bleeding. Secondary end-points include the individual rates of thromboembolism, valve thrombosis, and major bleeding, as well as the composite in subgroups of home or clinic-monitored INR and risk categorization for thromboembolism...
April 15, 2024: European Journal of Cardio-thoracic Surgery
https://read.qxmd.com/read/38502074/aspirin-for-metabolic-dysfunction-associated-steatotic-liver-disease-without-cirrhosis-a-randomized-clinical-trial
#2
RANDOMIZED CONTROLLED TRIAL
Tracey G Simon, Robert M Wilechansky, Stefania Stoyanova, Alessandra Grossman, Laura E Dichtel, Georg M Lauer, Karen K Miller, Yujin Hoshida, Kathleen E Corey, Rohit Loomba, Raymond T Chung, Andrew T Chan
IMPORTANCE: Aspirin may reduce severity of metabolic dysfunction-associated steatotic liver disease (MASLD) and lower the incidence of end-stage liver disease and hepatocellular carcinoma, in patients with MASLD. However, the effect of aspirin on MASLD is unknown. OBJECTIVE: To test whether low-dose aspirin reduces liver fat content, compared with placebo, in adults with MASLD. DESIGN, SETTING, AND PARTICIPANTS: This 6-month, phase 2, randomized, double-blind, placebo-controlled clinical trial was conducted at a single hospital in Boston, Massachusetts...
March 19, 2024: JAMA
https://read.qxmd.com/read/38492727/stroke-prevention-in-blunt-cerebrovascular-injury-role-of-aspirin-81-mg
#3
JOURNAL ARTICLE
Sina Asaadi, Christopher B Khoury, Julia Han, Martin G Rosenthal, Allen G Murga, Justin Dye, Kaushik Mukherjee, Miguel Lopez-Gonzalez, Ian Kershisnik, Marie L Crandall, Maryam B Tabrizi
BACKGROUND: The stroke rate in blunt cerebrovascular injury (BCVI) varies from 25% without treatment to less than 8% with antithrombotic therapy (ATT). There is no consensus on the optimal management to prevent stroke BCVI. We investigated the efficacy and safety of oral Aspirin (ASA) 81 mg to prevent BCVI-related stroke compared to historically reported stroke rates with ASA 325 mg and heparin. METHOD: A single-center retrospective study included adult trauma patients who received oral ASA 81 mg for BCVI management between 2013 and 2022...
March 14, 2024: Annals of Vascular Surgery
https://read.qxmd.com/read/38430972/aahks-clinical-research-award-extended-postoperative-oral-tranexamic-acid-in-total-knee-arthroplasty-a-randomized-controlled-pilot-study
#4
JOURNAL ARTICLE
Mateo J Kirwan, Zachary R Diltz, Derek T Dixon, Carlos A Rivera-Peraza, Christal J Gammage, Willliam M Mihalko, James W Harkess, James L Guyton, John R Crockarell, Marcus C Ford
INTRODUCTION: Perioperative tranexamic acid (TXA) use with total knee arthroplasty (TKA) is widely accepted today. Recently, a few international groups have published on the safety and outcomes of extending TXA use in the postoperative period. Through a double-blinded, randomized control trial, we aimed to investigate the safety and clinical efficacy of extended postoperative oral TXA use in TKA performed in an American, free-standing ambulatory surgery center (ASC). METHODS: Based on a power analysis, 40 patients undergoing primary TKA were randomized into two groups: extended oral TXA versus placebo...
February 29, 2024: Journal of Arthroplasty
https://read.qxmd.com/read/38398335/aspirin-at-75-to-81-mg-daily-for-the-prevention-of-preterm-pre-eclampsia-systematic-review-and-meta-analysis
#5
REVIEW
Brielle Demuth, Ariane Pellan, Amélie Boutin, Emmanuel Bujold, Louise Ghesquière
Background : Aspirin at 150 mg daily, initiated in the 1st trimester of pregnancy, prevents preterm pre-eclampsia. We aimed to estimate whether a dose of 75 to 81 mg daily can help to prevent preterm pre-eclampsia as well. Methods : A systematic search was conducted using multiple databases and meta-analyses of randomized controlled trials (RCTs) that compared aspirin initiated in the first trimester of pregnancy to placebo or no treatment, following the PRISMA guidelines and the Cochrane risk of bias tool...
February 10, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38388392/nintedanib-in-systemic-sclerosis-treatment-a-case-report
#6
JOURNAL ARTICLE
Maysoun Kudsi, Raghad Tarcha, Naram Khalayli
BACKGROUND: Nintedanib was approved for the treatment of scleroderma and scleroderma-related interstitial lung disease, as it decrease the forced expiratory volume. CASE PRESENTATION: A 48-year-old Asian female patient with systemic scleroderma 6 years ago developed breathlessness, nausea, heart palpation, and sudden severe occipital headache over the preceding week. She was receiving aspirin 81 mg/day and amlodipine 5 mg/day. Her diagnosis was diffuse scleroderma with pulmonary hypertension, interstitial lung involvement, and renal crisis...
February 23, 2024: Journal of Medical Case Reports
https://read.qxmd.com/read/38381842/effect-of-aspirin-versus-low-molecular-weight-heparin-thromboprophylaxis-on-medication-satisfaction-and-out-of-pocket-costs-a-secondary-analysis-of-a-randomized-clinical-trial
#7
JOURNAL ARTICLE
Nathan N O'Hara, Katherine P Frey, Deborah M Stein, Joseph F Levy, Gerard P Slobogean, Renan Castillo, Reza Firoozabadi, Madhav A Karunakar, Joshua L Gary, William T Obremskey, Rachel B Seymour, Joseph Cuschieri, C Daniel Mullins, Robert V O'Toole
BACKGROUND: Current guidelines recommend low-molecular-weight heparin for thromboprophylaxis after orthopaedic trauma. However, recent evidence suggests that aspirin is similar in efficacy and safety. To understand patients' experiences with these medications, we compared patients' satisfaction and out-of-pocket costs after thromboprophylaxis with aspirin versus low-molecular-weight heparin. METHODS: This study was a secondary analysis of the PREVENTion of CLots in Orthopaedic Trauma (PREVENT CLOT) trial, conducted at 21 trauma centers in the U...
February 21, 2024: Journal of Bone and Joint Surgery. American Volume
https://read.qxmd.com/read/38348779/age-and-aspirin-dosing-in-secondary-prevention-of-atherosclerotic-cardiovascular-disease
#8
JOURNAL ARTICLE
Guillaume Marquis-Gravel, Amanda Stebbins, Lisa M Wruck, Matthew T Roe, Mark B Effron, Bradley G Hammill, Jeff Whittle, Jeffrey J VanWormer, Holly R Robertson, Jacqueline D Alikhaani, Sunil Kripalani, Peter M Farrehi, Saket Girotra, Catherine P Benziger, Tamar S Polonsky, J Greg Merritt, Kamal Gupta, Thomas E McCormick, Kirk U Knowlton, Sandeep K Jain, Ajar Kochar, Russell L Rothman, Robert A Harrington, Adrian F Hernandez, W Schuyler Jones
BACKGROUND: In patients with atherosclerotic cardiovascular disease, increasing age is concurrently associated with higher risks of ischemic and bleeding events. The objectives are to determine the impact of aspirin dose on clinical outcomes according to age in atherosclerotic cardiovascular disease. METHODS AND RESULTS: In the ADAPTABLE (Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-Term Effectiveness) trial, patients with atherosclerotic cardiovascular disease were randomized to daily aspirin doses of 81 mg or 325 mg...
February 13, 2024: Journal of the American Heart Association
https://read.qxmd.com/read/38324415/apixaban-to-prevent-recurrence-after-cryptogenic-stroke-in-patients-with-atrial-cardiopathy-the-arcadia-randomized-clinical-trial
#9
JOURNAL ARTICLE
Hooman Kamel, W T Longstreth, David L Tirschwell, Richard A Kronmal, Randolph S Marshall, Joseph P Broderick, Rebeca Aragón García, Pamela Plummer, Noor Sabagha, Qi Pauls, Christy Cassarly, Catherine R Dillon, Marco R Di Tullio, Eldad A Hod, Elsayed Z Soliman, David J Gladstone, Jeff S Healey, Mukul Sharma, Seemant Chaturvedi, L Scott Janis, Balaji Krishnaiah, Fadi Nahab, Scott E Kasner, Robert J Stanton, Dawn O Kleindorfer, Matthew Starr, Toni R Winder, Wayne M Clark, Benjamin R Miller, Mitchell S V Elkind
IMPORTANCE: Atrial cardiopathy is associated with stroke in the absence of clinically apparent atrial fibrillation. It is unknown whether anticoagulation, which has proven benefit in atrial fibrillation, prevents stroke in patients with atrial cardiopathy and no atrial fibrillation. OBJECTIVE: To compare anticoagulation vs antiplatelet therapy for secondary stroke prevention in patients with cryptogenic stroke and evidence of atrial cardiopathy. DESIGN, SETTING, AND PARTICIPANTS: Multicenter, double-blind, phase 3 randomized clinical trial of 1015 participants with cryptogenic stroke and evidence of atrial cardiopathy, defined as P-wave terminal force greater than 5000 μV × ms in electrocardiogram lead V1, serum N-terminal pro-B-type natriuretic peptide level greater than 250 pg/mL, or left atrial diameter index of 3 cm/m2 or greater on echocardiogram...
February 20, 2024: JAMA
https://read.qxmd.com/read/38321799/added-value-of-mean-blood-pressure-and-placental-growth-factor-in-the-early-detection-of-pre-eclampsia-among-gabonese-women
#10
JOURNAL ARTICLE
Elisabeth Lendoye, Ulysse Pascal Minkobame, Opheelia Makoyo Komba, Pamphile Assoumou Obiang, Luce Nkene Eya'a, Ulrich Bisvigou, Lydie Moukambi, Bénédicte Ndeboko, Jacques Albert Bang Ntamack, Edgard Brice Ngoungou, Joël Fleury Djoba Siawaya, Félix Ovono Abessolo, Jean François Meyé
OBJECTIVE: To evaluate the use of the Foetal Medicine Foundation (FMF) algorithm in routine practice for early pre-eclampsia (PE) screening in Libreville. MATERIALS AND METHODS: We conducted a cohort study on pregnant women within their 11-13 + 6 weeks of gestation (WG). We had measured mean blood pressure (MBP), placental growth factor (PlGF), soluble Fms-like tyrosine kinase 1, Uterine Artery Pulsatility Index (UtA-PI) and resistance index (UtA-RI). Statistical analyses were considered significant for P < 0...
January 1, 2024: Nigerian Postgraduate Medical Journal
https://read.qxmd.com/read/38306624/extemporaneous-compounding-of-low-strength-aspirin-capsules-for-desensitization-protocols
#11
JOURNAL ARTICLE
Carly Messenger, Bailey Soper, Kara Cutaia, Fang Zhao
Aspirin is a non-steroidal, anti-inflammatory drug used for a range of indications. For patients with aspirin hypersensitivities, a desensitization procedure may be prescribed, and the initial low doses of <81 mg need to be provided by compounded preparations. Compounding with aspirin is associated with stability challenges due to its poor chemical stability. Additionally, low-strength preparations often exhibit dosage accuracy and uniformity issues. This study was designed to assess the feasibility of compounding low-strength aspirin capsules for the use in desensitization protocols...
2024: International Journal of Pharmaceutical Compounding
https://read.qxmd.com/read/38283531/the-impact-of-aspirin-in-brain-tumor-surgery-to-stop-or-not-to-stop
#12
Jenny C Kienzler, Javier Fandino
Given the lack of guidelines regarding perioperative management of neurosurgical patients taking antiplatelet medication, a break of aspirin intake for elective brain surgery is recommended. To the best of our knowledge, only three clinical studies have been published comparing re-bleeding rates in patients undergoing elective brain surgery with and without aspirin. We present a case of an 81-year-old woman who was admitted for elective craniotomy and brain metastases resection. She presented with a right-sided hemianopsia for > two weeks and further investigation by magnetic resonance imaging (MRI) showed the left occipital lesion...
December 2023: Curēus
https://read.qxmd.com/read/38281770/principal-stratification-analysis-of-noncompliance-with-time-to-event-outcomes
#13
JOURNAL ARTICLE
Bo Liu, Lisa Wruck, Fan Li
Post-randomization events, also known as intercurrent events, such as treatment noncompliance and censoring due to a terminal event, are common in clinical trials. Principal stratification is a framework for causal inference in the presence of intercurrent events. The existing literature on principal stratification lacks generally applicable and accessible methods for time-to-event outcomes. In this paper, we focus on the noncompliance setting. We specify 2 causal estimands for time-to-event outcomes in principal stratification and provide a nonparametric identification formula...
January 29, 2024: Biometrics
https://read.qxmd.com/read/38262066/neurodevelopment-of-children-whose-mothers-were-randomized-to-low-dose-aspirin-during-pregnancy
#14
JOURNAL ARTICLE
Matthew K Hoffman, Shivaprasad Goudar, Sangappa Dhaded, Lester Figueroa, Manolo Mazariegos, Nancy F Krebs, Jamie Westcott, Shiyam Sunder Tikmani, Fatima Karim, Sarah Saleem, Robert L Goldenberg, Adrien Lokangaka, Antoinette Tshefu, Melissa Bauserman, Archana Patel, Prabir Das, Patricia Hibberd, Elwyn Chomba, Musaku Mwenchanya, Waldemar A Carlo, Marissa Trotta, Alexis Williams, Janet Moore, Tracy Nolen, Norman Goco, Elizabeth M McClure, Michele A Lobo, Andrea B Cunha, Richard J Derman
OBJECTIVE: Because low-dose aspirin is now commonly prescribed in pregnancy, we sought to assess the association between early antenatal exposure and child neurodevelopment. METHODS: We performed a noninferiority, masked, neurodevelopmental follow-up study of children between age 33 and 39 months whose mothers had been randomized to daily low-dose aspirin (81 mg) or placebo between 6 0/7 and 13 6/7 weeks of gestation through 37 weeks. Neurodevelopment was assessed with the Bayley-III (Bayley Scales of Infant and Toddler Development, 3rd Edition) and the ASQ-3 (Ages and Stages Questionnaire, 3rd Edition)...
January 23, 2024: Obstetrics and Gynecology
https://read.qxmd.com/read/38240348/thromboembolism-prophylaxis-practices-of-pediatric-and-congenital-electrophysiologists-during-invasive-electrophysiology-studies-a-paces-survey
#15
JOURNAL ARTICLE
Suneet Bhansali, Michael Antonchak, Frank Cecchin, Reina Bianca Tan
BACKGROUND: Thromboembolic events related to invasive electrophysiology studies, while rare, can have devastating consequences. Use of systemic anticoagulation for a pediatric or adult-congenital invasive electrophysiology study is recommended, however there is no established standard of practice in this population. OBJECTIVE: To report on procedural practices for thromboembolism prophylaxis during invasive electrophysiology studies for pediatric patients and adults with congenital heart disease...
January 19, 2024: Pacing and Clinical Electrophysiology: PACE
https://read.qxmd.com/read/37994553/an-aspirin-free-versus-dual-antiplatelet-strategy-for-coronary-stenting-stopdapt-3-randomized-trial
#16
RANDOMIZED CONTROLLED TRIAL
Masahiro Natsuaki, Hirotoshi Watanabe, Takeshi Morimoto, Ko Yamamoto, Yuki Obayashi, Ryusuke Nishikawa, Kenji Ando, Takenori Domei, Satoru Suwa, Manabu Ogita, Tsuyoshi Isawa, Hiroyuki Takenaka, Takashi Yamamoto, Tetsuya Ishikawa, Itaru Hisauchi, Kohei Wakabayashi, Yuko Onishi, Kiyoshi Hibi, Kazuya Kawai, Ruka Yoshida, Hiroshi Suzuki, Gaku Nakazawa, Takanori Kusuyama, Itsuro Morishima, Koh Ono, Takeshi Kimura
BACKGROUND: Bleeding rates on dual antiplatelet therapy (DAPT) within 1 month after percutaneous coronary intervention (PCI) remain high in clinical practice, particularly in patients with acute coronary syndrome or high bleeding risk. Aspirin-free strategy might result in lower bleeding early after PCI without increasing cardiovascular events, but its efficacy and safety have not yet been proven in randomized trials. METHODS: We randomly assigned 6002 patients with acute coronary syndrome or high bleeding risk just before PCI either to prasugrel (3...
February 20, 2024: Circulation
https://read.qxmd.com/read/37980890/treatment-strategies-and-prognosis-for-moderate-stroke-patients-in-china
#17
JOURNAL ARTICLE
Liyuan Wang, Qi Zhou, Hongqiu Gu, Manjun Hao, Yunyun Xiong, Yongjun Wang
INTRODUCTION: Moderate stroke patients with National Institutes of Health Stroke Scale (NIHSS) score of 4-10 and without intravenous thrombolysis or endovascular treatment are basically excluded from current secondary prevention trials. We aimed to explore the effectiveness of mono- vs. dual-antiplatelet (DAPT) treatment strategies against subsequent stroke for these patients in a nationwide cohort. METHODS: Data were derived from the Third China National Stroke Registry (CNSR-Ш)...
November 18, 2023: Cerebrovascular Diseases
https://read.qxmd.com/read/37952132/apixaban-for-stroke-prevention-in-subclinical-atrial-fibrillation
#18
RANDOMIZED CONTROLLED TRIAL
Jeff S Healey, Renato D Lopes, Christopher B Granger, Marco Alings, Lena Rivard, William F McIntyre, Dan Atar, David H Birnie, Giuseppe Boriani, A John Camm, David Conen, Julia W Erath, Michael R Gold, Stefan H Hohnloser, John Ip, Josef Kautzner, Valentina Kutyifa, Cecilia Linde, Philippe Mabo, Georges Mairesse, Juan Benezet Mazuecos, Jens Cosedis Nielsen, Francois Philippon, Marco Proietti, Christian Sticherling, Jorge A Wong, David J Wright, Ignatius G Zarraga, Shelagh B Coutts, Andrew Kaplan, Marta Pombo, Felix Ayala-Paredes, Lizhen Xu, Kim Simek, Sandra Nevills, Rajibul Mian, Stuart J Connolly
BACKGROUND: Subclinical atrial fibrillation is short-lasting and asymptomatic and can usually be detected only by long-term continuous monitoring with pacemakers or defibrillators. Subclinical atrial fibrillation is associated with an increased risk of stroke by a factor of 2.5; however, treatment with oral anticoagulation is of uncertain benefit. METHODS: We conducted a trial involving patients with subclinical atrial fibrillation lasting 6 minutes to 24 hours...
January 11, 2024: New England Journal of Medicine
https://read.qxmd.com/read/37944745/venous-thromboembolism-prophylaxis-in-shoulder-surgery-a-break-even-cost-effectiveness-study
#19
JOURNAL ARTICLE
Brandon J Martinazzi, Christopher M Stauch, Peter F Monahan, Jesse L King, Kempland C Walley, Gregory J Kirchner, April D Armstrong, Gary F Updegrove
BACKGROUND: Venous thromboembolism (VTE) is a serious complication following orthopedic shoulder surgery; however, research is limited involving the break-even cost-effectiveness of VTE prophylaxis. The purpose of this study was to determine if the cost of aspirin and enoxaparin would break even for VTE prevention in patients following shoulder surgery. METHODS: A drug retail database was used to obtain the lowest price for a course of aspirin (81 mg) and enoxaparin (40 mg) to perform a break-even cost analysis...
November 7, 2023: Journal of Shoulder and Elbow Surgery
https://read.qxmd.com/read/37901619/monitoring-delayed-toxoplasmosis-related-branch-retinal-artery-occlusion-using-widefield-en-face-optical-coherence-tomography-and-multimodal-imaging
#20
Prashanth Iyer, Noy Ashkenazy, Jeremy Liu, Diana Laura, Marilyn Ann Marquez, Thomas Albini
Ocular toxoplasmosis has a known, rare association with acute retinal artery occlusion (RAO). We describe a 21-year-old male who presented with acute focal toxoplasmosis chorioretinitis in the right eye treated with intravitreal clindamycin, intravitreal dexamethasone, and adjunct oral therapy for vision-threatening retinitis with subsequent quiescence. Nine months from his initial presentation, the patient presented with a branch RAO adjacent to an inactive retinal scar in the right eye. Widefield en face structural swept-source optical coherence tomography (SS-OCT) centered on the middle retina showed paracentral acute middle maculopathy (PAMM) in an arteriolar distribution...
2023: Case Reports in Ophthalmology
keyword
keyword
39967
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.